4D pharma has leveraged growing knowledge in the field, by creating a novel class of medicines called live biotherapeutic products (LBPs). Never miss a story ...
Defining the microbiome space is 4D pharma and its pioneering live biotherapeutic products (LBPs), an emerging class of medicines based on single strains of commensal bacteria. “We understand ...
D Molecular Therapeutics reported 52-week Phase 2b data for 4D-150 in wet AMD, showing sustained visual acuity improvements.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback